Recently, the "Expert Consensus on the Prevention and Treatment of Novel Coronavirus Pneumonia with Traditional Chinese Medicine" was formulated, it was undertaken by the Respiratory Drug Research Professional Committee of the China Association of Traditional Chinese Medicine, with reference to the National Health Commission and the State Administration of Traditional Chinese Medicine issued the "Novel Coronavirus Pneumonia Diagnosis and Treatment Program (Seventh Edition)" and "Novel Coronavirus Pneumonia Diagnosis and Treatment Program (Eighth Edition"). Edition)", by Professor Sun Zengtao, Director of the Tianjin Institute of Respiratory Diseases, Chairman of the Special Committee of Respiratory Medicine Research of China Association of Traditional Chinese Medicine, Director of the Department of Respiratory Medicine of China-Japan Friendship Hospital, and Chairman of the Special Committee of Respiratory Medicine Research of China Association of Traditional Chinese Medicine Lin Lin Professor Jiang Tao, director of the cadre health care office of the China-Japan Friendship Hospital, and professor Zhang Hongchun, chairman of the Pulmonary Disease Branch of the Chinese Association of Traditional Chinese Medicine, served as the team leader. The consensus has been officially published online in the "Chinese Journal of Integrative Medicine", and Livzon antiviral granules are included in it. The experts pointed out that for mild patients (clinical manifestations are mainly fever, sore throat, fatigue), and common patients (clinical manifestations are mainly fever, body aches, cough, sore throat, shortness of breath), Livzon antiviral granules are recommended.

Livzon Antiviral granules (Reg No. for sugar-free type: Z20010127; Reg No. for sugar type: Z20070007) was developed by Sichuan Guangda Pharmaceutical Co., Ltd., a subsidiary of Livzon Group, according to the classic prescription. It is the exclusive traditional Chinese medicine compound preparation for the treatment of upper respiratory tract infection and influenza, it is included in the National Medical Insurance Catalogue 2019 of Traditional Chinese Medicines for Clearing Heat and Detoxification Category B, the National Traditional Chinese Medicine Protection Variety (Secondary), "National Innovative Product", "Sichuan Famous New Product ", "Chengdu Famous Products". The indications are clearing heat and removing dampness, cooling blood and detoxifying. For colds with wind-heat, fever with febrile diseases, and excess heat in the lungs and guards, symptoms include fever, headache, cough, dry throat, sore throat, upper respiratory tract infection, influenza, and mumps with the above-mentioned syndromes. A number of studies have shown that it is effective in treating symptoms such as nasal congestion, runny nose, fever, sore throat, headache, fever, and head and body pain.